Literature DB >> 2429560

Fate of pancreatic enzymes during small intestinal aboral transit in humans.

P Layer, V L Go, E P DiMagno.   

Abstract

To determine survival of pancreatic enzymes during small intestinal aboral transit in humans, seven healthy volunteers were intubated with an oroileal tube. By using nonabsorbable markers we measured the cumulative amount of lipase, trypsin, and amylase activities and lipase and trypsin immunoreactivities delivered postprandially to the duodenum, midjejunum, and terminal ileum. We found that as the enzymes moved from duodenum to ileum, 74% of amylase activity, 22% of trypsin activity, and 1% of lipase activity survived transit. Enzymatic activity and immunoreactivity of trypsin and lipase disappeared at different rates, suggesting that for these enzymes the sites of enzymatic activity and immunorecognition are not identical. Since tryptic activity is present even in the absence of immunorecognizable trypsin, complete structural integrity of the trypsin molecule may not be essential for its enzymatic activity. The short intraluminal survival of lipolytic activity may partially explain why patients with progressive exocrine pancreatic insufficiency malabsorb fat earlier than other nutrients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429560     DOI: 10.1152/ajpgi.1986.251.4.G475

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

Review 1.  Chymotrypsin C mutations in chronic pancreatitis.

Authors:  Jiayi Zhou; Miklós Sahin-Tóth
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

Review 2.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

3.  Amylase level in extrahepatic bile duct in adult patients with choledochal cyst plus anomalous pancreatico-biliary ductal union.

Authors:  In-Ho Jeong; Yong-Sik Jung; Hong Kim; Bong-Wan Kim; Jung-Woon Kim; Jeong Hong; Hee-Jung Wang; Myung-Wook Kim; Byung-Moo Yoo; Jin-Hong Kim; Jae-Ho Han; Wook-Hwan Kim
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 4.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 5.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

6.  The role of malabsorption in bariatric surgery.

Authors:  Vivek N Prachand; John C Alverdy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

Review 7.  Uses and abuses of enzyme therapy in cystic fibrosis.

Authors:  P Durie; D Kalnins; L Ellis
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

8.  Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.

Authors:  András Szabó; Evette S Radisky; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 9.  Pancreatic enzymes in chronic pancreatitis.

Authors:  P Layer; G Holtmann
Journal:  Int J Pancreatol       Date:  1994-02

10.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.